TABLE 4.
Donor-related reasons for disqualification from the LKD program.
| Medical n (%) | n = 139 |
| mGFR < 70 mL/min/1.73 m2# | 42 (30.2) |
| Nephrological* | 14 (10.1) |
| Urological** | 12 (8.6) |
| Cardiovascular risk factors | |
| Hypertension (poorly controlled with more than two medications) | 17 (12.9) |
| Diabetes or pathological oGTT | 14 (10.1) |
| Smoking | 9 (6.5) |
| Arteriosclerosis | 6 (4.3) |
| BMI > 35 kg/m2 (without weight loss in the work-up) | 23 (16.5) |
| Age (too young) | 7 (5.0) |
| Malignancy | 28 (20.1) |
| In recent past medical history | 7 (5.0) |
| Diagnosed during work-up | 21 (15.1) |
| Psychiatric | 7 (5.0) |
| Lung disease | 4 (2.9) |
| Genetical predisposition for kidney disease | 3 (2.2) |
| Active infectious disease (Hepatitis B/C, TBC, or HIV) | 4 (2.9) |
| Other*** | 5 (3.6) |
| Psychosocial n (%) | n = 41 |
| Psychological assessment | 10 (24.3) |
| Insufficient bond between donor and recipient | 5 (12.2) |
| Other social aspects**** | 15 (36.5) |
| Uncertainty for transplantation | 5 (12.2) |
| Signs of coercion | 2 (4.9) |
| Financial problems | 6 (14.6) |
| Non-adherence | 4 (9.8) |
| Religion | 2 (4.9) |
| Immunological§ n (%) | n = 52 |
| Positive crossmatch | 21 (40.4) |
| Donor specific HLA Antibodies | 31 (59.6) |
#As assessed by renal nuclear scan. *Includes incidental unclear microhematuria and/or proteinuria, newly diagnosed kidney disease (e.g., Alport syndrome). **Includes incidental abnormal kidney cysts, abnormal kidney vessels or ureter, unclear incidental macrohematuria and/or nephrolithiasis or high risk for nephrolithiasis. ***Includes neurological abnormalities (newly diagnosed multiple sclerosis), one case of Merkelsson-Rosenthal Syndrome, and gastrointestinal abnormalities. ****Includes difficult social circumstances such as single parents of small children, planning child conception. Some candidates qualified for more than one category. n, number; mGFR, measured glomerular filtration rate; oGTT, oral glucose tolerance test; HIV, Human immunodeficiency virus; HLA, human leucocyte antigen; TBC, tuberculosis.
§donor-related contraindications depending on the potential recipient.